CD19 and antisynthetase syndrome: Pecher and colleagues described a case of a 41-year-old male patient with anti-Jo-1 antisynthetase syndrome refractory to previous treatment lines (rituximab, azathioprine), who received 1.23 × 106 CD19 CAR-T cells/kg after LDC with fludarabine (25 mg/m2 days −5 to −3) and CYC (1000 mg/m2 day −3) [39].